BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8832608)

  • 1. Nephrotoxicity of low-dose methotrexate in guinea pigs: an ultrastructural study.
    el-Badawi MG; Abdalla MA; Bahakim HM; Fadel RA
    Nephron; 1996; 73(3):462-6. PubMed ID: 8832608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light and electron microscopic observations on the cerebellum of guinea pigs following low-dose methotrexate.
    el-Badawi MG; Fatani JA; Bahakim H; Abdalla MA
    Exp Mol Pathol; 1990 Dec; 53(3):211-22. PubMed ID: 2257929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
    J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to rescue high-dose methotrexate induced nephrotoxicity and literature review about hemodiafiltration?
    Yang YY; Gao L; Ding N; Wang XB; Zhang LP; Gao LH; Wang Z
    Pak J Pharm Sci; 2020 May; 33(3):1163-1167. PubMed ID: 33191243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural evaluation of the effect of N-acetylcysteine on methotrexate nephrotoxicity in rats.
    Çağlar Y; Özgür H; Matur I; Yenilmez ED; Tuli A; Gönlüşen G; Polat S
    Histol Histopathol; 2013 Jul; 28(7):865-74. PubMed ID: 23307329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
    Pitman SW; Frei E
    Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe methotrexate toxicity precipitated by intravenous radiographic contrast.
    Harned TM; Mascarenhas L
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):496-9. PubMed ID: 17609630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
    Cohen IJ
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1057-1065. PubMed ID: 28455583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one-month repeated oral dose toxicity study of methotrexate in unilaterally nephrectomized rats.
    Murakami Y; Yamazaki K; Sakauchi N; Ogasawara H; Yamashita N; Masuda T; Tauchi K
    J Toxicol Sci; 1998 Nov; 23 Suppl 5():681-99. PubMed ID: 9891907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation by different mechanisms of the protective effects of vitamin B12 on methotrexate nephrotoxicity.
    Ozturk E; Karabulut D; Akin AT; Kaymak E; Kuloglu N; Yakan B
    J Mol Histol; 2022 Feb; 53(1):133-143. PubMed ID: 34655350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin nephrotoxicity: report of a case with light and electron microscopic studies.
    Ito J; Johnson WW; Roy S
    Acta Pathol Jpn; 1969 Feb; 19(1):55-67. PubMed ID: 5820328
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of vitamin E on adriamycin- induced nephrotoxicity at the ultrastructural level in guinea pigs.
    Görgün M; Erdogan D; Abban G; Türközkan N; Elbeg S
    Nephron; 1999 Jun; 82(2):155-63. PubMed ID: 10364708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of silymarin on methotrexate-induced nephrotoxicity in rats.
    Dabak DO; Kocaman N
    Ren Fail; 2015 May; 37(4):734-9. PubMed ID: 25707519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methotrexate-leucovorin rescue therapy: pharmacological characteristics and clinical effective use].
    Fujimoto T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1901-6. PubMed ID: 8978794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of poly(ADP-ribose) polymerase (PARP) activation in methotrexate-induced nephrotoxicity and tubular apoptosis.
    Dalaklioglu S; Sahin P; Ordueri EG; Celik-Ozenci C; Tasatargil A
    Int J Toxicol; 2012; 31(5):430-40. PubMed ID: 22914891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
    Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
    N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.
    Parker LM; Griffiths CT; Yankee RA; Knapp RC; Canellos GP
    Cancer Treat Rep; 1979 Feb; 63(2):275-9. PubMed ID: 312692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose leucovorin as sole therapy for methotrexate toxicity.
    Flombaum CD; Meyers PA
    J Clin Oncol; 1999 May; 17(5):1589-94. PubMed ID: 10334548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.